Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice Article

publication date

  • August 1, 2021

webpage

published in

keywords

  • PIC1
  • RLS-0071
  • acyclovir-resistance
  • anti-inflammatory
  • antiviral
  • complement
  • herpes simplex type 1
  • neutrophil
  • wound healing
  • zosteriform infection

volume

  • 13

issue

  • 8